Children's Oncology Group Hospital Membership and Survival of Pediatric Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) predominates in children ages 0-14 years and has an excellent prognosis for cure with 5-year survival exceeding 90% in the United States. However, not all children experience such positive outcomes. The purpose of this quantitative, retrospective cohort study was t...
Main Author: | Betts, Paul David |
---|---|
Format: | Others |
Language: | en |
Published: |
ScholarWorks
2017
|
Subjects: | |
Online Access: | https://scholarworks.waldenu.edu/dissertations/3862 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4965&context=dissertations |
Similar Items
-
Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age
by: Lara Devilli, et al.
Published: (2021-03-01) -
Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia
by: Rachana Chennamaneni, et al.
Published: (2018-01-01) -
Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
by: Hiroto Inaba, et al.
Published: (2021-04-01) -
Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019
by: Małgorzata Czogała, et al.
Published: (2021-09-01) -
Development of an immune‐related prognostic model for pediatric acute lymphoblastic leukemia patients
by: Xi Quan, et al.
Published: (2020-09-01)